# Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03)

> **NCT05938374** · PHASE2 · COMPLETED · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 52 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Fluzoparib
- **RADIATION:** Preoperative moderately fractionated radiotherapay

## Key facts

- **NCT ID:** NCT05938374
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05938374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05938374, "Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05938374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*